BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36503509)

  • 21. Assessment of peritoneal elastic laminal invasion improves survival stratification of pT3 and pT4a colorectal cancer: a meta-analysis.
    Odate T; Vuong HG; Mochizuki K; Oishi N; Kondo T
    J Clin Pathol; 2019 Nov; 72(11):736-740. PubMed ID: 31471468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The impact of modified T3 sub-staging on the prognosis of gallbladder cancer patients].
    Chen C; Zhang D; Li Q; Lei JJ; Geng ZM
    Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):302-308. PubMed ID: 38432671
    [No Abstract]   [Full Text] [Related]  

  • 23. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
    Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
    Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
    Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extramural venous invasion and depth of extramural invasion on preoperative CT as prognostic imaging biomarkers in patients with locally advanced ascending colon cancer.
    Cho J; Kim YH; Kim HY; Chang W; Park JH
    Abdom Radiol (NY); 2022 Nov; 47(11):3679-3687. PubMed ID: 36066635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of perineural invasion in stages II and III colorectal cancer.
    Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
    Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perineural Invasion is a Major Prognostic and Predictive Factor of Response to Adjuvant Chemotherapy in Stage I-II Colon Cancer.
    Cienfuegos JA; Martínez P; Baixauli J; Beorlegui C; Rosenstone S; Sola JJ; Rodríguez J; Hernández-Lizoáin JL
    Ann Surg Oncol; 2017 Apr; 24(4):1077-1084. PubMed ID: 27624582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of metachronous peritoneal metastases in patients with pT4a versus pT4b colon cancer: An international multicentre cohort study.
    Bastiaenen VP; Aalbers AGJ; Arjona-Sánchez A; Bellato V; van der Bilt JDW; D'Hoore AD; Espinosa-Redondo E; Klaver CEL; Nagtegaal ID; van Ramshorst B; van Santvoort HC; Sica GS; Snaebjornsson P; Wasmann KATGM; de Wilt JHW; Wolthuis AM; Tanis PJ
    Eur J Surg Oncol; 2021 Sep; 47(9):2405-2413. PubMed ID: 34030920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer.
    Uil SH; Coupé VMH; Bril H; Meijer GA; Fijneman RJA; Stockmann HBAC
    BMC Cancer; 2022 Apr; 22(1):372. PubMed ID: 35395779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer].
    Qin Q; Yang L; Zhou AP; Sun YK; Song Y; DU F; Wang JW
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):212-6. PubMed ID: 23880003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathomics Signature for Prognosis and Chemotherapy Benefits in Stage III Colon Cancer.
    Jiang W; Wang H; Dong X; Yu X; Zhao Y; Chen D; Yan B; Cheng J; Zhuo S; Wang H; Yan J
    JAMA Surg; 2024 May; 159(5):519-528. PubMed ID: 38416471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of perineural invasion on survival in node negative colon cancer.
    Mirkin KA; Hollenbeak CS; Mohamed A; Jia Y; El-Deiry WS; Messaris E
    Cancer Biol Ther; 2017 Sep; 18(9):740-745. PubMed ID: 28475454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.
    Peng J; Zhang R; Zhao Y; Wu X; Chen G; Wan D; Lu Z; Pan Z
    Chin J Cancer; 2017 Dec; 36(1):96. PubMed ID: 29268783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perineural invasion is a prognostic factor in stage II colorectal cancer but not a treatment indicator for traditional chemotherapy: a retrospective cohort study.
    Li J; Mei S; Zhou S; Zhao F; Liu Q
    J Gastrointest Oncol; 2022 Apr; 13(2):710-721. PubMed ID: 35557585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obstruction is associated with perineural invasion in T3/T4 colon cancer.
    Nozawa H; Morikawa T; Kawai K; Hata K; Tanaka T; Nishikawa T; Sasaki K; Shuno Y; Kaneko M; Hiyoshi M; Emoto S; Murono K; Sonoda H; Fukayama M; Ishihara S
    Colorectal Dis; 2019 Aug; 21(8):917-924. PubMed ID: 31017742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
    Zhi C; Yang W; Li N; Zhang Z; Hua Y; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):172-179. PubMed ID: 30799540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
    An MS; Yoo JH; Kim KH; Bae KB; Choi CS; Hwang JW; Kim JH; Kim BM; Kang MS; Oh MK; Hong KH
    World J Surg Oncol; 2015 Feb; 13():64. PubMed ID: 25889520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macroscopic serosal invasion and small tumor size as independent prognostic factors in stage IIA colon cancer.
    Lee SY; Kim CH; Kim YJ; Kim HR
    Int J Colorectal Dis; 2018 Aug; 33(8):1139-1142. PubMed ID: 29705939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.